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Daptomycin is the first approved drug from a new class of antimicrobials, the cyclic lipopeptides, and is a 
very important antimicrobial agent in current clinical practice. Currently, there are no “green” analytical 
methods described in the literature to analyze the typical pharmaceutical dosage form of daptomycin. 
Thus, the aim of this work was to validate an environment-friendly spectrophotometric method in the 
UV region, for the analysis of daptomycin as a lyophilized powder. Water was used as diluent and the 
analyses were carried out on a spectrophotometer at 221 nm. The method met all validation requirements 
of the ICH guidelines, over a concentration range of 6-21 µg mL-1. A Student’s t-test demonstrated that 
the proposed method was comparable to an HPLC method previously validated. Thus, the validated 
spectrophotometric method could quantify daptomycin in a powder form for injectable solutions, while 
being an economical, rapid, and “green” alternative for routine analysis in quality control.
Uniterms: Antimicrobials/quality control. Daptomycin/determination. Spectrophotometry/UV region/
quantitative analysis. Spectrophotometry/green analytical method.
A daptomicina é o primeiro membro aprovado de uma nova classe de antimicrobianos, os lipopeptídeos 
cíclicos, e é muito importante para a prática clínica atualmente. Não existem métodos analíticos “verdes” 
descritos na literatura para a análise da daptomicina na forma farmacêutica. Desta forma, o objetivo 
deste trabalho foi a validação de método espectrofotométrico na região do UV ambientalmente favorável 
para análise da daptomicina em pó liofilizado. A água foi escolhida como diluente e as análises foram 
realizadas em 221 nm. O método atendeu a todas as exigências de validação dos guias do ICH, na faixa 
de 6-21 µg mL-1. Teste t de Student mostrou que o método proposto é intercambiável com método de 
HPLC previamente validado. Assim, o método espectrofotométrico validado é capaz de quantificar a 
daptomicina em pó para solução injetável e é uma opção econômica, rápida e “verde” para análises de 
rotina do controle de qualidade deste fármaco.
Unitermos: Antimicrobianos/controle de qualidade. Daptomicina/determinação. Espectrofotometria/ 
região do UV/análise quantitativa. Espectrofotometria/método analítico verde.
INTRODUCTION
It is widely known that microbial resistance 
is a major problem worldwide. Many bacteria have 
developed resistance to a large number of antimicrobial 
agents available on the market; these bacteria are 
considered challenges for medicine. Methicillin-resistant 
Staphylococcus aureus (MRSA) and vancomycin resistant 
enterococci (VRE) are two examples of antimicrobial-
resistant microorganisms (Silveira et al., 2006; Wright, 
2011). Compounding the problem of antimicrobial 
resistance, there are few new antimicrobial agents 
emerging in the market (Wright, 2011).
One recent development in antimicrobial treatment 
is the introduction of daptomycin into the marketplace 
(Figure 1). This is the first antimicrobial agent from 
the cyclic lipopeptide class approved for use in clinical 
practice in the United States in 2003, and currently in 
more than 40 countries worldwide (Lopes, 2008; Pirri et 
al., 2009; Sweetman, 2011). 
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Daptomycin has a mechanism of action that is 
distinct from all other antimicrobial agents available in 
the market. For this reason, it is able to overcome the 
mechanisms of resistance that many resistant strains have 
developed. It has been used successfully in treating some 
infections caused by resistant gram-positive bacteria, 
such as MRSA and VRE. Furthermore, resistance to 
daptomycin is rare worldwide (Silveira et al., 2006; Picazo 
et al., 2011; Brunton, Chabner, Knollman, 2012; Chitnis 
et al., 2013; Sader et al., 2014).
The quality of medicines has always been a concern 
to the World Health Organization (WHO), because without 
the assurance that these products meet the standards of 
quality, safety, and efficacy, worldwide health services can 
be affected. In addition, governments allocate a substantial 
part of their health budget to purchasing medicines. For 
these reasons, the WHO advocates for the availability 
of a reliable system of quality control of medicines in 
all countries (WHO, 2007). Thus, worldwide interest in 
research involving medications is increasing, particularly 
with respect to their quality control. Research that involves 
the development of new analytical methods is essential 
to optimize the analysis of medicines in the industry, and 
guarantees the quality of products already marketed. 
In addition to the concern about the quality of 
analytical data, there is also concern about the environmental 
impact of industrial activity. Increasingly, companies are 
seeking environmentally friendly alternatives to their 
routine processes, adopting a commitment to reducing, 
preventing, or eliminating harmful waste. There are actions 
that companies can take to reduce the environmental 
burden, including the replacement of analytical techniques 
that employ organic solvents with techniques that do not 
(Nolasco, Tavares, Bendassoli, 2006).
A few published studies in the literature describe the 
development of analytical methods to analyze daptomycin. 
Most of these studies are directed towards biological fluid 
analysis by high performance liquid chromatography 
(HPLC), (Tobin et al., 2008; Martens-Lobenhoffer et al., 
2008; Baietto et al., 2010; Gika et al., 2010; Olszowy et 
al., 2010; Polillo et al., 2010; Verdier et al., 2011; Szultka 
et al., 2013) and ultra-performance liquid chromatography 
(UHPLC) (Gikas et al., 2010a; Gikas et al., 2010b; Bazoti 
et al., 2011; Baietto et al., 2014; Naito et al., 2014). In 
addition, there are no monographs of this drug in any 
official compendium. One study using HPLC was found 
in the literature describing an analytical method for the 
analysis of daptomycin in its pharmaceutical powdered 
dosage form (Christ et al., 2014). 
Most of the reported analytical methods employed 
techniques that are not considered ecologically friendly 
in analytical laboratories. Furthermore, the methods that 
used liquid chromatography require toxic solvents or high 
volumes of solvents for drug quantification, which is more 
expensive and unhealthy for the laboratory staff and the 
community.
Spectrophotometric instrumental methods are 
considered simple, fast, inexpensive, and reproducible. In 
addition, they can be developed without the use of organic 
solvents, which makes this technique more environmental-
friendly (Moreno, Salgado, 2009; Bonfílio, Araújo, 
Salgado, 2011; Cazedey, Salgado, 2012; Fiorentino, 
Salgado, 2012; Silva, Almeida, Salgado, 2012; Pedroso, 
Salgado, 2013; Cazedey, Salgado, 2014; Chierentin, 
Salgado, 2014; Corrêa, Serra, Salgado, 2014). To our 
knowledge, there are no studies in the literature that used 
spectrophotometry to analyze daptomycin.
Considering the importance of daptomycin in 
clinical practice, and the advantages of spectrophotometric 
methods, the main objective of the present study was 
the development of a fast and environmentally friendly 
ultraviolet (UV) spectrophotometric analytical method 
for the quantitative analysis of this drug in its lyophilized 
powder form. As a control, we used a high performance 
liquid chromatography (HPLC) method, previously 
developed and validated by our study group, as a 
comparative method in the determination of this drug.
EXPERIMENTAL
Equipment
To perform the spectrophotometric analysis, a 
FIGURE 1 - Chemical structure of daptomycin.
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ShimadzuTM UV-Vis UV-1800 model spectrophotometer 
(Shimadzu, Japan) was used. This equipment was 
connected to a computer loaded with the UV-ProbeTM 
software. Microsoft Excel (2013) was used to construct 
the calibration curves. In order to evaluate the robustness 
of this method, we also used a ShimadzuTM UV-Vis UV 
mini-1240 model spectrophotometer (Kyoto, Japan).
For comparative HPLC analysis, we used a model 
1525 Waters HPLC (Waters Chromatography systems, 
USA), connected to a Waters 2487 UV/Visible detector, 
and a manual injector Rheodyne Breeze 7725i with a 20 
µL loop (Rheodyne Breeze, USA). The chromatographic 
separation was carried out using isocratic reversed phase 
conditions on an Agilent ZorbaxTM C18, 5 µm, 4.6 x 150 
mm (Agilent, USA).
The following equipment was also used: 20-200 µL 
micropipettes (DigipetTM, Brazil) and an H51 analytical 
scale (Mettler ToledoTM, Switzerland).
Chemicals and reagents
Daptomycin (DPT) reference standard (DPT 
RS) (purity of 98.00%) was purchased from Sequoia 
Research Products Company (Sequoia, UK). Samples 
containing 500 mg of daptomycin, as a lyophilized 
powder for injectable solution, (CubicinTM, Novartis, 
USA) were purchased on the market. The pharmaceutical 
form contains sodium hydroxide as an excipient. For 
this reason, sodium hydroxide (Vetec, Brazil) was also 
used. The solvent used was purified water (obtained by 
reverse osmosis - Millipore, USA). In order to evaluate 
the robustness of the method, purified water obtained 
through Milli-Q Plus equipment (Millipore, USA) was 
also used.
Spectrophotometric measurements
UV-Vis spectra of reference and sample solutions 
were measured using 1-cm quartz cells, and a fast scan 
speed. Purified water, obtained by reverse osmosis, 
was used as blank solution for the spectrophotometric 
measurements. A 221 nm wavelength was used to develop 
the present method.
Chromatographic conditions
In order to compare the results of the proposed 
spectrophotometric method with a reference method, the 
same DPT batch was analyzed using an HPLC technique 
previously developed and validated by our study group. 
We performed this experiment in isocratic mode, and 
the mobile phase consisted of ethanol and water (55:45; 
v/v) with the pH adjusted to 4.5 using glacial acetic acid. 
Chromatographic separation was achieved using an 
Agilent ZorbaxTM C18 analytical column (150 x 4.6 mm; 
5 µm) (AgilentTM, USA). The volume of the injection 
was 20 µL and the flow rate was 0.6 mL min-1. Room 
temperature was maintained at 25 ºC. The peak areas 
detected at 221 nm were defined as analytical signs, with 
detection at 221 nm.
Preparation of solutions
Stock and working standard solutions
For the preparation of the DPT RS stock solution, 
5.0 mg of DPT RS was weighed, then transferred and 
diluted with purified water to a volume of 50 mL in a 
volumetric flask, yielding a solution with a concentration 
of 100 µg mL-1.
Working DPT RS solutions were prepared 
immediately before use, using purified water to dilute the 
corresponding stock solution to appropriate concentration 
levels. For the HPLC analysis, the stock and working 
standard solutions were diluted with mobile phase.
Stock and working sample solutions
DPT sample stock solution at a theoretical 
concentration of 100 µg mL-1 was prepared. For this 
purpose, the average weight of three vials of DPT in 
powder for injectable solution was calculated. The contents 
of these vials were mixed, and an amount equivalent to 
5.0 mg of DPT was accurately weighted, transferred to 
the 50-mL volumetric flask, and diluted to 50 mL with 
purified water, yielding a stock solution of 100 µg mL-1. 
Appropriate dilutions were made using the same diluent, 
in order to obtain the working sample solutions. For the 
HPLC analysis, the stock and working sample solutions 
were diluted with mobile phase.
Preparation of stock sodium hydroxide solution 
(placebo)
A solution containing 1000 µg mL-1 of sodium 
hydroxide was prepared. To prepare the solution, 10 
mg of NaOH was weighed, transferred to a 10 mL 
volumetric flask, and diluted to 10 mL with purified water. 
Appropriate dilutions were made using the same diluent, in 
order to obtain a placebo solution with the correct NaOH 
concentration.
Calculation of the DPT content in the sample
The DPT content in the lyophilized powder sample 
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was calculated by using Equation 1 and its percentage 
content was calculated by using Equation 2.
  Equation 1
  Equation 2
where: CS = concentration of DPT in the sample (µg mL
-1); 
CS% = percentage concentration of DPT in the sample; 
CRS = concentration of DPT RS solution (µg mL
-1); 
AS = absorbance of DPT sample solution; ARS = absorbance 
of DPT RS solution; Ct = theoretical concentration of DPT 
in the sample (µg mL-1).
Method validation
The method was validated by determining the 
following parameters: linearity, precision, accuracy, 
robustness, selectivity, detection, and quantification limits, 
in accordance with recommendations in the literature 
(ICH, 2005; ANVISA, 2010; USP, 2014).
Linearity
In order to analyze the linearity of the method, 
three analytical curves, performed on three different days, 
were evaluated. For this purpose, aliquots of 0.3, 0.45, 
0.6, 0.75, 0.9, and 1.05 mL of the stock DPT standard 
solution were transferred to 5 mL volumetric flasks, and 
diluted to 5 mL with purified water. This resulted in DPT 
RS working solutions with concentrations of 6.0, 9.0, 
12.0, 15.0, 18.0, and 21.0 µg mL-1. Each concentration 
was prepared in triplicate (n = 3) and spectrophotometric 
analysis was conducted at a wavelength of 221 nm. The 
results were evaluated by linear regression analysis, which 
was calculated by the least square method, and the linearity 
was verified by analysis of variance (ANOVA).
Precision
Accuracy of the method was evaluated in two 
different ways: by repeatability and intermediate 
precision. Repeatability (or intraday precision) was 
assessed by the analysis of DPT RS working solutions 
(n = 6) at a concentration of 12.0 µg mL-1, which were 
prepared and analyzed on the same day and under similar 
experimental conditions. The percent relative standard 
deviation (RSD%) of the measurements was calculated 
and evaluated. Intermediate precision (inter-day and 
between different analysts) was evaluated by determining 
DPT content in the samples of lyophilized powder on three 
different days, and by a second analyst, under the same 
experimental conditions. RSD% values were calculated 
between the determinations (ICH, 2005).
Accuracy
Accuracy of the method was determined by 
measuring the reference standard recovery in triplicate 
at three levels (R1, R2 and R3), from 80 to 120% of 
the method concentration (12.0 µg mL-1), according to 
ICH recommendations (ICH, 2005). For this purpose, 
the stock solutions of DPT RS and DPT as a powder 
for injectable solution (100 µg mL-1) were prepared as 
described in previous sections. From the sample stock 
solution, aliquots of 0.30 mL were transferred to three 5 
mL volumetric flasks. Then aliquots of 0.18, 0.30, and 
0.42 mL from the DPT RS stock solution were added. 
The flasks were then filled with purified water, obtaining 
solutions with concentrations of 9.6, 12.0, and 14.4 µg 
mL-1, which is equivalent to 80 (R1), 100 (R2), and 
120% (R3) of the working concentration. The mean 
recoveries, expressed in terms of percent recovery from 
the pharmaceutical dosage form (CubicinTM 500 mg) by 
the assay, and the respective relative standard deviation 
(R.S.D.), were calculated using the equation described 
by the Association of Analytical Chemists (AOAC) 
(AOAC, 2002).
Robustness
In order  to evaluate the robustness of  the 
method, the following parameters were individually 
altered: wavelength (measured at 219 and 223 nm), 
spectrophotometer (tested with a ShimadzuTM UV mini-
1240 model), and an alternative source of water (Milli-Q 
water). Robustness was evaluated by performing DPT 
content determinations in the sample of lyophilized 
powder under the different conditions. The DPT content 
calculated under the modified conditions was compared 
with the results obtained under the normal working 
conditions, according to the RSD% between the results.
Selectivity
In order to evaluate the selectivity of the method, a 
spectrum obtained with DPT RS solution at a concentration 
of 12 µg mL-1 was compared with the spectrum obtained 
with a placebo solution. This determined whether there 
was any interference from placebo in the DPT analysis. 
The DPT RS solution was prepared as described 
in previous sections. The placebo solution, in turn, 
was prepared using sodium hydroxide, as it is the 
only other constituent of the DPT sample excipient. A 
concentration of 1.03 µg mL-1 was used, equivalent to the 
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concentration of NaOH present in 12 µg mL-1 solution of 
DPT in lyophilized powder. This percentage of NaOH was 
calculated according to the average weight of three vials of 
DPT as a powder for injectable solution. To conduct this 
test, an aliquot of 51.5 µL from the stock placebo solution 
at 1000 µg mL-1 was transferred to a 50 mL volumetric 
flask, the volume was adjusted to 50 mL with purified 
water, and then the solution was adequately homogenized.
D P T  R S  a n d  p l a c e b o  s o l u t i o n s  w e r e 
spectrophotometrically analyzed in the UV region (200-
400 nm) and their absorption spectra were compared.
Detection and quantification limits
Detection and quantification limits were calculated 
based on the intercept standard deviations, and the curve 
inclinations from the linear regression, as described in the 
literature (ICH, 2005). 
Comparison of methods
In order to compare the spectrophotometric 
and chromatographic methods, DPT sample content 
determinations were performed using both methods. The 
results of the determinations obtained by spectrophotometry 
in the UV region were statistically compared with those 
obtained with the HPLC method, using a Student’s t test 
at a level of significance of p < 0.05.
RESULTS AND DISCUSSION
General aspects and method development
Fast and practical analytical methods to quantify 
daptomycin in either the pharmaceutical dosage form 
or other forms have not been previously published. The 
existing methods to analyze this important antimicrobial 
agent require large volumes of organic solvents and 
sophisticated equipment. In addition, most of these 
methods analyze daptomycin in biological fluids, 
rather than the pharmaceutical dose. In this study, water 
was chosen as the diluent, since it is inexpensive and 
not hazardous to laboratory staff or the environment; 
the choice of this diluent makes the present method 
economical, safe, practical, and environmental-friendly.
In a recent literature search, an excellent paper 
detailing the advances made in green pharmaceutical 
research was discovered (Cue, Zhang, 2009). In this paper, 
the authors expressed hope, and had high expectations, 
that the concepts presented will lead to new ecological 
methodologies to quantify drugs. They discuss case 
studies of the successful modification of processes to 
achieve reduced resource requirements, waste generation, 
or energy consumption. The authors also expressed hope 
that there will be increased emphasis on green chemistry in 
pharmaceutical research and manufacturing. In response to 
environmental concerns, pharmaceutical researchers have 
concentrated their focus and creative energies towards 
minimizing and optimizing the environmental impact of 
their craft. Therefore, with many compounds in queue for 
therapeutic screening, ecologically friendly changes to 
the standard processes and current analytical methods that 
allow for increased throughput are welcome.
To develop the current method, DPT RS UV 
spectra were obtained in multiple solvents to confirm the 
suitability of water as a diluent. DPT RS was observed 
to be soluble in all tested solvents (water, methanol, 
0.1 mol L-1 NaOH and 0.1 mol L-1 HCl); the spectra are 
presented in Figure 2.
The maximum absorption wavelength was 221 nm 
when using water as a diluent. The wavelength was slightly 
lower, at 220.2 nm, when 0.1 mol L-1 HCl was used as the 
diluent. The other two solvents tested as diluents, methanol 
and 0.1 mol L-1 NaOH, had maximum absorptions at 
223.6 and 223.0 nm, respectively. The spectra obtained 
with 0.1 mol L-1 NaOH and 0.1 mol L-1 HCl had a lower 
absorption peak at the maximum absorption wavelength, 
suggesting DPT degradation. 
Since the spectra were similar between water and 
methanol, water was chosen as the diluent in the validation 
of this quantitative method, owing to its economic and 
environmental advantages. The use of water as a diluent 
is very relevant to the pharmaceutical industries, since 
analytical methods that do not use organic solvents for 
analysis are sought after in order to reduce the impacts of 
their activities on the environment.
Method validation
Linearity
Three calibration curves, generated on three 
separate days, were constructed by plotting the average 
absorbances at 221 nm with respect to the concentrations. 
The final analytical curve, constructed using the average of 
the three analytical curves, yielded a correlation coefficient 
(r) greater than 0.999 (Table I).
A l inear  correla t ion between the DPT RS 
concentrations and the respective mean absorbances 
was observed within the studied range. The correlation 
coefficient value indicates the high degree of linearity 
using this method.
In addition, the data were validated using analysis 
of variance (ANOVA), which revealed significant linear 
E. G. Tótoli, H. R. N. Salgado816
regression, since the Fcalculated (18820.25) was higher that 
the Fcritical (4.75), while no significant linearity deviation 
was detected, since the Fcalculated (0.33) was lower than the 
Fcritical (3.26). This analysis was performed at a significance 
level of 5% (p < 0.05).
Precision
The precision of the method was evaluated in 
two different ways: repeatability (intraday precision) 
and intermediate precision (interdays and inter-analyst 
precisions). The intermediate precision results are 
presented in Table II. The intraday precision (n = 6) gave 
an RSD value of 1.20%.
The RSD% values observed were lower than 
1.20%, which confirms the appropriate precision of the 
method.
Accuracy
The accuracy of the method was determined using a 
recovery assay performed at three different concentration 
levels (Table III). The data demonstrates adequate accuracy 
of the method, since the experimental concentrations were 
very close to the real values (close to 100%).
Robustness
Robustness of the method was determined, 
demonstrating the reliability of the analysis regarding 
small variations in the working parameters. The results 
FIGURE 2 - Ultraviolet absorption spectra of DPT RS solution at a concentration of 12 µg mL-1. The DPT RS was dissolved using 
the following diluents: a) water; b) methanol; c) 0.1 mol L-1 HCl and d) 0.1 mol L-1 NaOH.
TABLE I - Linearity parameters for the determination of DPT
Parameter Result
Linearity range (µg mL-1) 6.0 to 21.0
Slope 0.0299 ± 0.0003ª
Intercept 0.0095 ± 0.0013a
Correlation coefficient 0.9999 ± 0.0003ª
a Values are reported as mean ± standard deviation (S. D.) of 
three analytical curves generated on three consecutive days 
(n = 3).
TABLE II - Intermediate precision of the spectrophotometric method to determine DPT content
Interdays Between analysts
Sample Day Content
a (g/
vial)
Contenta 
(%) RSD (%) Analyst
Contenta (g/
vial)
Contenta 
(%) RSD (%)
1
1 0.517 103.45
1.11
1 0.519 103.74
0.13
2 0.514 102.76 2 0.518 103.55
3 0.525 105.02
a mean of three determinations (n = 3)
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TABLE III - Accuracy of the spectrophotometric method for the determination of DPT concentration
Added DPT RS / µg 
mL-1
DPT RS founda / 
µg mL-1
Recovery 
(%)
RSD (%) 
(n = 3)
Average recovery 
(%)
R1 3.60 3.60 100.01 1.43
R2 6.00 5.97 99.58 0.03 99.94
R3 8.40 8.42 100.23 1.06
a average of three determinations.
TABLE IV - Robustness of the spectrophotometric method for determining DPT concentration
Variable Range investigated
Content 
(g/vial)
Content 
(%)
RSD (%)
Wavelenght (nm)
219 
221a 
223
0.514 
0.519 
0.513
102.89 
103.74 
102.63
0.56
Spectrophotometer
UV-Vis ShimadzuTM, 
UV-1800 modela 
UV-Vis ShimadzuTM, UV 
mini-1240 model
0.519 
 
0.513
103.74 
 
102.57
0.81
Source of water
Reverse osmosisa 
Milli-Q
0.519 
0.519
103.74 
103.76
0.01
a Standard working conditions.
show that the validity of the method was maintained, even 
with small variations in the method´s working conditions 
(Table IV) (ICH, 2005). 
The calculated RSD% values were below 0.81%, 
proving that small variations in the working conditions 
will not interfere with the analysis of DPT.
Selectivity
Figure 3 (a) shows the overlap of the spectra 
obtained with DPT RS solution and placebo solution 
(NaOH). Figure 3 (b) shows the overlap of the spectra 
obtained with DPT RS and lyophilized powder solutions. 
It was observed that the formulation excipient of the 
DPT in lyophilized powder did not interfere with the 
UV spectrophotometric method, since the excipient did 
not have any absorption bands that may have interfered 
with the analysis of DPT, in the wavelength used in 
this method. Thus, the selectivity of the method was 
confirmed.
Detection and quantification limits
The limits of detection (LOD) and quantification 
(LOQ) were calculated to determine the sensitivity of the 
method. The calculated value for the LOD was 0.14 µg 
mL-1 and the LOQ was 0.42 µg mL-1. These values indicate 
FIGURE 3 – a) Overlap of the absorption spectra of DPT RS 
(12 µg mL-1) and placebo (NaOH) solutions, using water as 
the solvent; b) Overlap of the absorption spectra of DPT RS 
(12 µg mL-1) and lyophilized powder (12 µg mL-1) solutions, 
using water as the solvent.
the ability of this method to reliably detect and quantify 
DPT in its pharmaceutical dosage form.
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Assay of the pharmaceutical product and comparison 
between methods
The comparison between analytical methods is an 
important tool to determine if the procedures are equivalent. 
Thus, in order to compare the spectrophotometric method 
proposed in this work with a previously validated HPLC 
method, statistical analysis of the DPT content (as a 
lyophilized powder) was performed using Student’s t 
test (p < 0.05). The percentage contents of daptomycin 
calculated using both methods are shown in Table V.
Statistical analysis revealed that the DPT contents 
determined by both methods were statistically equivalent, 
since the tcalculated (0.51) was lower than the tcritical (2.78). 
Thus, these methods are interchangeable for the 
quantitative analysis of daptomycin in the pharmaceutical 
dosage form.
Although the statistical analysis demonstrated that 
both techniques are interchangeable, there are a number 
of differences between these methods to take into account 
when considering their advantages and disadvantages.
HPLC is one of the most commonly used techniques 
for the quantitative analysis of drugs in the pharmaceutical 
industry. This method presents some advantages, such as 
the ability to perform analysis in a short time, the ability 
to analyze complex mixtures owing to its high resolution, 
easy and accurate quantitative analysis, good sensitivity, 
and versatility, since it allows the analysis of a wide range 
of substances. In addition, it allows for the automation 
of analysis, making it convenient to conduct to routine 
analysis. On the other hand, one of the major disadvantages 
is the high cost of instrumentation and operation, since this 
technique requires expensive chromatographic columns 
and high-purity organic solvents (Collins, Braga, Bonato, 
1997). Additionally, this technique uses large volumes of 
organic solvents for analysis, which makes it a source of 
occupational exposure and environmental contamination.
In contrast, UV spectrophotometry, in many cases, 
can be developed in an environmental-friendly way 
without the use of organic solvents, as demonstrated in 
the present work. However, even when the use of organic 
solvents is necessary, this technique is still advantageous 
when compared to HPLC, since it requires smaller 
amounts of organic solvents than the chromatographic 
method. As the UV spectrophotometry method does not 
require the use of costly chromatographic columns and 
high purity solvents, this technique is also economically 
advantageous. This cost advantage is even greater when 
the method uses water as the diluent, as it is a low cost 
solvent. Another advantage of this technique is the short 
time to conduct analysis, which makes it a practical 
option for routine analysis in quality control. However, 
one downside of UV spectrophotometry is that it is not 
able to detect and separate degradation products, unlike 
the HPLC.
CONCLUSION
In the present study, the UV spectrophotometric 
analytical method was properly developed, validated, and 
shown to be effective for the quantification of daptomycin 
in its pharmaceutical dosage form as a lyophilized powder 
for injectable solution. This method has advantages when 
compared to chromatographic methods, such as employing 
an aqueous system, rather than potentially toxic organic 
solvents, and it requires minimal sample preparation 
steps. In addition, spectrophotometric analysis uses 
small amounts of solvents and sample, resulting in a non-
polluting method for staff and the environment. 
This procedure uses simple reagents, requires 
minimal sample preparation, and generates only a small 
amount of residue. Therefore, its use is encouraged 
for routine analysis. The proposed method might 
be successfully used in the quantitative analysis of 
pharmaceutical formulations of daptomycin, contributing 
to improvements in medication quality control. In addition, 
a Student’s t-test showed no statistically significant 
difference between the proposed UV spectrophotometric 
method and a previously validated HPLC method. Given 
these results, both methods are interchangeable, however 
the spectrophotometric method is environmentally and 
economically advantageous compared to the HPLC 
method.
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